A new target for differentiation therapy in AML
Despite major advances in understanding the genetics and epigenetics of acute myelogenous leukemia,there is still a great need to develop more specific and effective therapies.High throughput approaches involving either genetic approaches or small molecule inhibitor screens are beginning to identify promising new therapeutic targets.
27
2017-02-27(万方平台首次上网日期,不代表论文的发表时间)
9-10